WO2016176042A1 - Systèmes et procédés pour fournir des surfaces de prise de notes sur des pompes à perfusion - Google Patents

Systèmes et procédés pour fournir des surfaces de prise de notes sur des pompes à perfusion Download PDF

Info

Publication number
WO2016176042A1
WO2016176042A1 PCT/US2016/027254 US2016027254W WO2016176042A1 WO 2016176042 A1 WO2016176042 A1 WO 2016176042A1 US 2016027254 W US2016027254 W US 2016027254W WO 2016176042 A1 WO2016176042 A1 WO 2016176042A1
Authority
WO
WIPO (PCT)
Prior art keywords
flap
receptacle
pump
syringe
structured
Prior art date
Application number
PCT/US2016/027254
Other languages
English (en)
Inventor
James B. DROST
Stacy A. SCHULTZ
Eric J. WILKOWSKE
Original Assignee
Smiths Medical Asd, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smiths Medical Asd, Inc. filed Critical Smiths Medical Asd, Inc.
Publication of WO2016176042A1 publication Critical patent/WO2016176042A1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/145Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
    • A61M5/1452Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons
    • A61M5/1456Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons with a replaceable reservoir comprising a piston rod to be moved into the reservoir, e.g. the piston rod is part of the removable reservoir
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/50General characteristics of the apparatus with microprocessors or computers
    • A61M2205/502User interfaces, e.g. screens or keyboards

Definitions

  • This disclosure relates to infusion pumps, and more particularly, to systems and methods for providing note-taking surfaces on infusion pumps.
  • Infusion pumps are useful medical devices for providing medicaments to patients.
  • medications such as antibiotics, chemotherapy drugs, and pain relievers are commonly delivered to patients via infusion pumps, as are nutrients and other supplements.
  • Infusion pumps have been used in hospitals, nursing homes, and in other short-term and long- term medical facilities, as well as for in-home care. Infusion pumps can be particularly useful for the delivery of medical therapies requiring an extended period of time for their administration.
  • PCA patient- controlled analgesia
  • Infusion pumps are typically useful in various routes of medicament delivery, including intravenously, intra-arterially, subcutaneously, intradermally, intraperitoneally, in close proximity to nerves, and into an intraoperative site, epidural space or subarachnoid space.
  • Caregivers using infusion pumps often need or wish to keep track of multiple pieces of information, for example, relating to medicaments being used with the pump, patient care, and so on. Retaining and organizing such transient information can be a challenge. In view of the goal of simplifying caregiver workloads, it would be desirable to provide systems and methods for providing note-taking surfaces on infusion pumps.
  • This disclosure relates to infusion pumps, and more particularly, to systems and methods for providing note-taking surfaces on infusion pumps.
  • the disclosure provides an infusion pump that can include a receptacle configured to receive a syringe and a receptacle flap that can be pivotably attached to the pump.
  • the receptacle flap can be pivotable between an open mode and a closed mode, where in the closed mode, the receptacle flap is in a position that substantially inhibits access to the receptacle and to the syringe received by the receptacle, and in the open mode, the receptacle flap is in a position that enables access to the receptacle and to the syringe received by the receptacle.
  • the receptacle flap can include a surface structured for erasably marking with a compatible marking device.
  • the pump can include a flap latch configured to selectively constrain the receptacle flap to the closed mode.
  • the pump can include a clamp assembly configured to releasably secure the syringe in the receptacle, where the clamp assembly is structured also to function as the flap latch.
  • the pump can include a flap release mechanism configured to enable the receptacle flap to be selectively attached to and separably released from the pump.
  • the flap release mechanism can include an attachment portion of the receptacle flap and a flap attachment point fixed relative to the pump, with the attachment portion and the flap attachment point being configured to reversibly mate.
  • the flap release mechanism can be configured to be actuatable to selectively release the receptacle flap relative to the pump only when the receptacle flap is in the open mode, and not actuatable to release the receptacle flap when the receptacle flap is in the closed mode.
  • the flap release mechanism can be configured to be actuatable to selectively release the receptacle flap relative to the pump without use of any tool.
  • the attachment portion of the receptacle flap can be structured with at least one subcomponent that moves between a first position and a second position, such that when the receptacle flap is attached and secured to the pump, the at least one subcomponent is deployed in the first position, and when the receptacle flap is configured to be attachable and detachable relative to the pump, the at least one subcomponent is deployed in the second position.
  • the flap attachment point can be structured with at least one subcomponent that moves between a first position and a second position, such that when the receptacle flap is attached and secured to the pump, the at least one subcomponent is deployed in the first position, and when the pump is configured for the flap to be attachable and detachable relative to the pump, the at least one subcomponent is deployed in the second position.
  • the disclosure provides a selectively removable flap configured to selectively attach to an infusion pump proximal a syringe receptacle of the infusion pump.
  • the selectively removable flap cab include a cover portion dimensioned to inhibit access to the syringe receptacle and to a syringe received by the receptacle when the selectively removable flap is positioned in a closed mode, with the cover portion including a surface structured for erasably marking with a compatible marking device.
  • the selectively removable flap can also include an attachment portion fixed relative to the cover portion and structured to mate with a flap attachment point of the infusion pump.
  • the attachment portion and the flap attachment point can provide a flap release mechanism configured to enable the selectively removable flap to be selectively attached to and separably released from the infusion pump.
  • the flap release mechanism can be configured to enable the selectively removable flap to move between the closed mode and an open mode, where in the open mode, the cover portion is positioned to enable access to the receptacle and to the syringe received by the receptacle.
  • the cover portion can be substantially non-planar and shaped to conform in part to a shape of the syringe received by the receptacle.
  • the flap release mechanism can be configured to be actuatable to selectively release the receptacle flap relative to the pump only when the receptacle flap is in the open mode, and not to be actuatable to selectively release the receptacle flap when the receptacle flap is in the closed mode. In some examples, the flap release mechanism can be configured to be actuatable to selectively release the receptacle flap relative to the infusion pump without use of any tool.
  • an infusion pump can include a pump mechanism configured to deliver an infusate to a patient, a housing containing at least part of the pump mechanism, and a stack attached to and generally conforming to a surface of the housing.
  • the stack can include a bottom-most layer attached to the surface of the housing and a plurality of substantially identical removable overlying layers, with each of the overlying layers being removably adhered to an immediately underlying layer, and each of the overlying layers being structured for marking with a compatible marking device.
  • each of the overlying layers can be structured for erasably marking with a compatible erasable marking device.
  • the disclosure provides an infusion pump that can include a pump mechanism configured to deliver an infusate to a patient, a housing containing at least part of the pump mechanism, and a replaceable layer removably attached to and generally conforming to a surface of the housing, the replacable layer being structured for marking with a compatible marking device.
  • the replaceable layer can be structured for erasably marking with a compatible erasable marking device.
  • the disclosure provides an infusion pump that can include a pump mechanism configured to deliver an infusate to a patient, a note-taking surface, and a backlight configured to illuminate the note-taking surface, thereby rendering markings on the note-taking surface visible in darkened surroundings.
  • the note-taking surface can be structured for at least one of erasably marking with a compatible marking device, and/or receiving a replaceable layer, with the replacable layer being structured for marking with a compatible marking device.
  • the note-taking surface can overlay, at least in part, at least part of a dynamic display of the pump.
  • the note-taking surface can adjoin a dynamic display of the pump.
  • the backlight also can illuminate a dynamic display of the pump.
  • the pump can include the replaceable layer, with the replaceable layer being removably attached to the note-taking surface.
  • Figure 1 is a schematic front perspective view of an example of a syringe pump having a syringe receptacle flap;
  • Figure 2 is a schematic front perspective view of the syringe pump of Figure 1 with some features shown in other functional states;
  • Figure 3 is a schematic perspective view of another example of a syringe pump with a syringe receptacle flap;
  • Figure 4 is a schematic perspective view showing details of a receptacle flap detached from the pump illustrated in Figures 1 and 2;
  • Figure 5 is a schematic illustration of an example of a stack of peel-off note-taking surfaces.
  • the notes may also unintentionally cover or otherwise partially or totally obscure user interfaces and displays on the pumps. Also, supplies for notes (paper, tape, etc.) may not always be readily available for caregiver use.
  • the present disclosure provides systems and methods for providing note-taking surfaces on infusion pumps. Some of the solutions offered herein integrate note-taking surfaces with infusion pumps. Although syringe pumps are disclosed herein, any infusion pump could benefit from the subject matter of this disclosure.
  • FIGS 1 and 2 are schematic front perspective views of an example of an infusion pump embodied as a syringe pump 100.
  • syringe pump 100 can be similar to those of pumps described in the aforementioned U.S. Provisional Patent Application Serial No. 62/086,551, some of which are directed toward improving syringe security.
  • Syringe pump 100 can include any compatible feature described in the aforementioned provisional patent application, but it is not necessary for corresponding features of pump 100 to be the same as those of that provisional patent application, and such features of systems and methods for providing note-taking surfaces on infusion pumps, as described by example or otherwise contemplated herein, may differ therefrom.
  • pump 100 is illustrated in what may be deemed a secure state, in which some features of pump 100 are active or otherwise positioned or deployed to provide security for syringe 102, which is illustrated as being operatively mounted to the pump.
  • pump 100 is illustrated with some features in alternate states, relative to the configuration of Figure 1. In the following description, some cited features are more readily viewed in one or the other of Figures 1 and 2, and inspection of both Figures 1 and 2 may result in a better appreciation of the features of pump 100.
  • Syringe pump 100 can include a housing 104 generally enclosing an interior space and defining a space exterior to housing 104.
  • Pump 100 can include a receptacle 106 configured to receive a syringe such as syringe 102.
  • Receptacle 106 can be formed integrally with housing 104, although this is not necessary, and the receptacle can be provided on the outside of housing 104, although such arrangement also is not necessary.
  • Syringe 102 can be coupled to a line set or infusate tubing 103, through which medicaments and other infusates can be delivered from a reservoir of syringe 102.
  • Syringe pump 100 can include a pusher device 130 configured to couple to a thumb press 120 of plunger 118 of syringe 102.
  • pump 100 can drive pusher device 130 to exert a force on thumb press 120, thereby moving plunger 118 to expel contents of syringe 102 in an action of, for example, delivering the infusate to the patient through tubing 103.
  • Syringe pump 100 can include a retention mechanism configured to inhibit removal of syringe 102 from receptacle 106 when in an engaged state, and permit, allow, enable, or not inhibit removal of the syringe from the receptacle when in a disengaged state.
  • the retention mechanism can include different components or combinations of components.
  • the retention mechanism can include a clamp assembly 108 configured to releasably secure syringe 102 in receptacle 106.
  • Clamp assembly 108 can include a clamp grip 110 configured to bear against a barrel of syringe 102 as shown in Figure 1.
  • a portion 111 of clamp grip 110 that is configured to bear directly against the barrel of syringe 102 can have any suitable shape, such as a V-shape or a cupped- shape to facilitate clamping action of grip 110 against the barrel of syringe 102.
  • clamp grip 110 can exert a retaining force on syringe 102 into receptacle 106 and toward an inside space of housing 104. This can correspond to the engaged state of the retention mechanism.
  • clamp grip 110 is illustrated as bearing against the barrel of syringe 102.
  • Clamp assembly 108 can include a clamp arm 112 connected to clamp grip 110.
  • Clamp arm 112 can be slidably mounted relative to housing 104 such that clamp grip 110 is translatable both inwardly and outwardly relative to housing 104.
  • clamp arm 112 and clamp grip 110 are illustrated as being translated outwardly relative to housing 104, such that clamp grip 110 is not bearing against the barrel of syringe 102.
  • Clamp assembly 108 also can be structured so that clamp grip 110 can be rotated, as illustrated in Figure 2, although providing such rotational freedom is not required. Rotating clamp grip 110 may be useful for positioning it away from syringe receptacle 106 when a user wishes to remove or place a syringe therein.
  • Clamp assembly 108 can include a clamp lock mechanism (not shown in Figures 1 and 2) configured to releasably maintain clamp arm 112 at a syringe retention position where clamp grip 110 exerts the retaining force to secure syringe 102 in receptacle 106.
  • a clamp lock mechanism is described in further detail in the aforementioned U.S. Provisional Patent Application Serial No. 62/086,551.
  • Syringe pump 100 can include, in some examples, a receptacle flap 114 that is pivotably attached to pump 100.
  • receptacle flap 114 is pivotably attached to housing 104.
  • Receptacle flap 114 can be pivotable between a closed mode and an open mode. In the closed mode, shown for example in Figure 1, receptacle flap 114 can be in a position that substantially inhibits or prevents access to receptacle 106 and syringe 102 located therewithin.
  • receptacle flap 114 In the closed mode, receptacle flap 114 (more particularly, a cover portion 115 of flap 114) can substantially cover receptacle 106 and cover at least a substantial portion of syringe 102, when syringe 102 is located in receptacle 106.
  • cover portion 115 of receptacle flap 114 In the open mode, shown for example in Figure 2, cover portion 115 of receptacle flap 114 can be in a position or range of positions that substantially permit, allow, enable, or clear access to receptacle 106 and to syringe 102 therewithin.
  • flap 114 may physically obstruct or otherwise prevent touching all or part of the barrel of syringe 102, attaching/detaching or otherwise interacting with an attachment between syringe 102 and tubing 103, removing/placing syringe 102 from/in receptacle 106, or any other manner of access to syringe 102 that may be desirable to limit.
  • syringe 102 may be manually touched, removed from receptacle 106, placed in receptacle 106, attached/detached from tubing 103, and the like.
  • cover portion 1 15 of flap 1 14 might extend across only a relatively smaller portion of receptacle 106, or have any suitable length or shape.
  • cover portion 1 15 of flap 1 14 as illustrated in Figure 1 does not extend entirely around the barrel of syringe 102 (generally in the vertical or up/down directions relative to Figure 1), it could be taller or shorter or could have any suitable shape, and could, for example, essentially obstruct a large majority of receptacle 106.
  • Different shapes of flaps could be provided, for use with different syringe sizes and/or applications. Any suitable flap dimensions can be used.
  • Cover portion 1 15 of flap 1 14 can be substantially non-planar and can be shaped to conform in part to a shape of asyringe, such as syringe 102, received by receptacle 106.
  • flap 1 14 can include a substantially planar or flat portion sized to provide a useful note-taking surface, as discussed further herein.
  • receptacle flap 1 14 can form at least part of the retention mechanism of pump 100. In configurations where pump 100 includes receptacle flap 1 14 and clamp assembly 108, both components can work together as part of the retention mechanism. Clamp assembly 108 can be structured to constrain receptacle flap 1 14 to the closed mode when engaged to secure syringe 102 in receptacle 106.
  • clamp grip 1 10 of clamp assembly 108 can include structure (e.g., a left portion 1 16 of grip 1 10 in Figure 1) that overlaps with receptacle flap 1 14 in the closed mode when grip 1 10 is positioned to bear against the barrel of syringe 102, thereby interfering with or otherwise inhibiting rotation of flap 1 14 to the open mode, and thus constraining flap 1 14 to the closed mode.
  • structure e.g., a left portion 1 16 of grip 1 10 in Figure 1
  • grip 1 10 may be positioned such that it does not interfere with rotation of flap 1 14 between the closed and open modes and thus does not constrain flap 1 14 to the closed mode.
  • a component of clamp assembly 108 other than clamp grip 1 10 can be configured to constrain flap 1 14 to the closed mode when grip 1 10 is bearing against the barrel of syringe 102.
  • clamp assembly 108 can be considered to function as a flap latch.
  • FIG. 3 is a schematic front perspective view of an infusion pump 300 having a receptacle 306 and a receptacle flap 314 pivotably coupled to a pump housing 304.
  • Pump 300 can include a flap latch 318 configured to selectively constrain receptacle flap 314 in the closed mode.
  • Flap latch 318 can include an undulating or repetitively ridged shape, as illustrated, with multiple possible interference points that can provide for constraining receptacle flap 314 at multiple possible positions along latch 318 to accommodate, for example, multiple possible syringe sizes, although this is not limiting and latch 318 can take any suitable shape. Flap 314 and latch 318 can form at least part of the retention mechanism of pump 300.
  • a locking mechanism could be incorporated into a receptacle flap hinge (not shown). Any suitable locking mechanisms for receptacle flaps can be used.
  • illustrative syringe pump 300 of Figure 3 is structured with syringe receptacle 306 provided toward a bottom portion of housing 304
  • illustrative syringe pump 100 of Figures 1 and 2 is structured with syringe receptacle 106 provided toward a top portion of housing 104. While there may be relative advantages and disadvantages in some aspects with regard to top or bottom placement of syringe receptacles in various pump configurations, in general the novel and inventive features of the present disclosure may be practiced without particular regard to such placement.
  • a receptacle flap need not necessarily be permanently, or even quasi -permanently, attached to its respective pump.
  • receptacle flap 114 can be pivotably attached to syringe pump 100 via a flap release mechanism that is configured to enable flap 114 to be selectively attached to and separably released from pump 100. Any suitable flap release mechanism can be employed.
  • flap release mechanism of pump 100 may be discerned in Figures 1 and 2, and in Figure 4 which is a schematic front perspective view of receptacle flap 114 detached from pump 100.
  • the flap release mechanism can include components on or of both receptacle flap 114 and pump 100.
  • flap 114 can include an attachment portion 121 fixed relative to cover portion 115 of flap 114.
  • all or part of the attachment portion of a receptacle flap can be formed integrally or monolithically with the cover portion of the flap (for example, in a molding process) although this is not required.
  • Attachment portion 121 of flap 114 can be structured to reversibly mate with a flap attachment point 122 of infusion pump 100 that is fixed relative to pump 100.
  • attachment portion 121 and flap attachment point 122 can be structured with at least one moving subcomponent.
  • receptacle flap 114 as illustrated includes left-side and right-side moving pins 123 that can be slidingly moved or deployed outwardly and inwardly between first and second positions, with the outward first position corresponding to a state where the flap release mechanism is configured to secure flap 114 to pump 100, and the inward second position corresponding to a state where the flap release mechanism is configured to enable flap 114 to be attachable and detachable relative to pump 100.
  • Pins 123 are shown in the inward second position in Figure 2, and the outward first position in Figure 4.
  • the flap attachment point of the pump can include moving subcomponents deployable between first (flap secured) and second (flap non-secured) positions, possibly with the attachment portion of the receptacle flap essentially not having moving subcomponents.
  • the attachment portion of the flap can be structured to remain in a same configuration whether the flap release mechanism is configured to secure the flap to the pump, or is configured to enable the flap to be attachable and detachable relative to the pump.
  • Flap release mechanisms can be designed to be easily operated by a user of pump 100.
  • the flap release mechanism is actuatable to selectively attach and release receptacle flap 114 relative to pump 100 only when flap 114 is disposed in the open mode, and is not so actuatable when flap 114 is disposed in the closed mode.
  • features of the flap release mechanism such as moving pins 123 can be exposed to a user and can be manipulable to release or secure the flap; in Figure 1, with receptacle flap 114 disposed in the closed mode, the same features of the release mechanism are not exposed and in effect are inaccessible to a user for manipulation.
  • the flap release mechanism can be structured to be manipulable by an end user without the use of any tool. Alternately, in some cases, the flap release mechanism can be structured to require the use of a tool or tools for releasing receptacle flap 114 from pump 100 and/or securing the receptacle flap to the pump.
  • receptacle flap 314 and other contemplated flaps can likewise be configured similarly with release mechanisms.
  • receptacle flap 114 Once receptacle flap 114 has been detached, it or another compatible receptacle flap may be (re-)attached to pump 100 via the flap release mechanism.
  • the ability to remove and/or change receptacle flap 114 easily may provide valuable adaptability to pump 100. In some embodiments, it may be desired to not have a receptacle flap at all. In other embodiments, various receptacle flaps can provide various functionality to pump 100 for various applications and/or practitioner preferences. For example, in use of syringe pumps that do not involve controlled substances, a receptacle flap might not be configured to be constrainable to a closed mode.
  • receptacle flap 1 14 of syringe pump 100 of Figures 1 and 2 can be configured such that it can be constrained to the closed mode by clamp assembly 108
  • a non-security receptacle flap could be structured differently (e.g., with a different shape) such that the clamp assembly does not interfere with or otherwise constrain the rotation of the non-security receptacle flap regardless of the position of the clamp assembly, including when the clamp grip is bearing against the barrel of the syringe.
  • the receptacle flap might not constitute part of the syringe retention system of the infusion pump.
  • Receptacle flap 1 14 can be formed from opaque, transparent, or translucent material, in any suitable color. Color can be used to color-code a syringe pump as being intended for a particular use, using colors that are by convention associated with particular therapies. For example, the color orange is often associated with enteral infusions, and the color yellow is often associated with epidural infusions. It should be noted that these color associations are not universal and may vary between hospitals, institutions, regions, practices, etc. The ability to easily attach a customized receptacle flap can enable a caregiving organization to adapt the pump to the particular needs or desires of the organization. Receptacle flaps could be further customized with printed, molded, engraved, or otherwise imparted symbols, text, or any other desired marks.
  • Optical functionality can be provided with receptacle flaps.
  • Transparent and/or translucent receptacle flaps can provide a window through which a syringe may be viewed, providing a user with a direct visual path to assess the current status of the syringe. All or a portion of a transparent flap can be configured as a magnifier to assist visual inspection of a syringe.
  • a transparent and/or translucent receptacle flap can also be used as a lens or other optic to direct or otherwise manage light used to illuminate the syringe or other aspects of the pump.
  • a receptacle flap could be used as a light guide by injecting light into an edge of the flap, and extraction features patterned into the flap could direct light out of the flap and toward the syringe.
  • a configuration for placement of light emitters 129 of pump 100 to provide light in conjunction or cooperation with flap 1 14 is illustrated in Figure 4.
  • receptacle flap 1 14 can be structured to provide one or more convenient note- taking surfaces.
  • cover portion 1 15 of receptacle flap 1 14 can include a note-taking surface.
  • An outer surface and/or an inner surface of cover portion 1 15 of receptacle flap 1 14 can be structured as a note-taking surface.
  • Note-taking surfaces can be structured for marking with a compatible marking device, such as a pen, pencil, etc. In some embodiments, note-taking surfaces can be structured for erasably marking with a compatible erasable marking device.
  • Erasable marking devices can include dry-erase ink, pencil lead, or any other suitable marking media.
  • all or part of the receptacle flap can be formed from an erasable material, or coated with an erasable material, or otherwise include a surface having an erasable material.
  • Markable and/or erasably-markable surfaces can include, without limitation, melamine surfaces, polymer-coated metals or other substrates, enameled metals, porcelains, hardened laminates, painted surfaces, or any other suitable materials, including those used in white-boards, dry-erase boards, and the like.
  • Including a note-taking surface with receptacle flap 1 14 can provide a number of benefits. Providing a note-taking surface in close proximity to the infusate-containing syringe can, by proximity, imply an association of a note or notes written on the surface with the syringe. With a transparent receptacle flap 1 14, a marking or markings could be made on the note-taking surface of the receptacle flap overlying the syringe that directly correspond to volume markings of the syringe. An illuminated flap (e.g., lit by light emitters 129) could backlight a note or notes written on it, rendering them visible in low-light conditions.
  • housing 104 could be used for a note-taking surface or surfaces, so long as the surface or surfaces can be structured for marking with a compatible marking device, and particularly, for erasably marking with a compatible erasable marking device.
  • Some surfaces may be deemed more, or less appropriate for use as a note-taking surface.
  • a surface might be deemed less appropriate if written markings on the surface could lead to confusion with other markings or features of the device.
  • An example of a more appropriate or useful and less confusing surface might be a top of housing 104, which has a relatively large area and is located in a place where confusion with other pump features might be less likely to occur.
  • a possibly less advantageous aspect of providing note- taking surfaces on infusion pumps could be the possibility of degrading the pump' s visual appeal over time.
  • Some "erasable" surfaces can tend to stain or otherwise not completely erase with multiple uses, leading to a dingy, unclean, old, or otherwise unappealing appearance.
  • the detachable nature of receptacle flap 1 14 can provide a solution to this problem, enabling easy replacement of a degraded flap with a new or at least different or otherwise "clean" flap.
  • note-taking surfaces such as parts of housing 104
  • other solutions for providing clean note-taking surfaces are contemplated.
  • An embodiment that provides a clean note-taking surface includes attaching a stack of disposable peel-off note-taking surfaces on any suitable surface of an infusion pump, such as on the housing of the pump.
  • Figure 5 is a schematic illustration of a stack 500 of peel -off note-taking surfaces (illustrated with vertical exaggeration).
  • the stack can be formed to generally conform to the surface of the housing, and can be custom-shaped to specifically fit a particular location on the housing, or could be provided in a generic shape (e.g., rectangle) that might be placeable in multiple different locations and on different medical devices.
  • Stack 500 can include a plurality of substantially identical removable overlying layers 502 (the top-most layer is schematically shown as being partially peeled off). Each of the layers can be structured for marking with a compatible marking device on a top surface 504, and can include a suitable adhesive on a bottom surface 506, although adhesives may not be necessary in all embodiments. Each of the layers can be removably adhered to an immediately underlying layer.
  • the bottom-most layer 508 of the stack can be the same as the overlying layers, or can be different, for example, with a different adhesive suited for more securely anchoring the entire stack 500 to the housing surface.
  • the overlying layers can be structured on their top surfaces for erasably marking with a compatible erasable marking device, although this is not necessary in all embodiments.
  • the layers can be transparent or not transparent, of any suitable color.
  • the (currently) top-most layer of the stack can be removed to expose a fresh underlying layer. In addition to being visually clean, the fresh underlying layer can also be hygienically clean.
  • a single replaceable note-taking layer (not illustrated) can be removably attached to any suitable surface of an infusion pump, such as on the housing of the pump.
  • a single replaceable note-taking layer could be identical to a single one of the substantially identical removable overlying layers 502 of stack 500.
  • the single replaceable note-taking layer can be structured for erasably marking with a compatible erasable marking device. It could be replaced on an as-needed basis, with the need for replacement determined in any suitable way.
  • Replacement replaceable note-taking layers could be provided in a stack, from a roll, or in any suitable delivery/storage format. Replacement layers could be provided from a dispenser attached to a pump, an IV pole, a pump-rack, or in an equipment cabinet, or provided in any other suitable location.
  • the present disclosure contemplates systems and structures for providing illuminated note-taking surfaces readable in low-light conditions.
  • any suitable note-taking surface could be illuminated by a backlight configured to illuminate the surface.
  • Any suitable backlight technology could be used, such as LEDs or other light sources with a lightguide (and any other suitable light management films), electro-luminescent devices, "glow-in-the-dark” phosphorescent materials (incorporating phosphors such as zinc sulfide and/or strontium aluminate), and so on.
  • the backlight can underlie a surface structured to be (erasably) marked with a compatible (erasable) marking device, and/or a surface structured to receive a replaceable layer or a stack of layers, the layer(s) structured for (erasably) marking with a compatible (erasable) marking device.
  • a backlit note-taking surface can overlay or be adjacent to a dynamic display of an infusion pump.
  • a backlit area 150 can be provided on the front of pump 100 in conjunction with a dynamic display 152.
  • Dynamic display 152 can use any suitable display technology, such as liquid crystal display (LCD) or Organic Light Emitting Diode (OLED).
  • dynamic display 152 can be illuminated by the same backlight that illuminates a nondynamic display portion of backlit area 150, but this is not necessary, and in some embodiments dynamic display 152 can be illuminated by a separate backlight, or by an illumination mechanism that is not a backlight (for example, an OLED display provides its own illumination and is not backlit, although the OLED display could backlight a surface overlying the display).
  • All or part of backlit area 150 can be provided as a note-taking surface that is structured for erasably marking with a compatible marking device, or for receiving a replaceable layer or a stack of layers that can be (erasably) marked.
  • All or part of the surface overlying dynamic display 152 can be structured as a note-taking surface (with note markings potentially overlying dynamically-displayed information), and/or all or part of the surface overlying dynamic display 152 can be structured not as a note-taking surface (for example, potentially including coatings or other materials engineered not to readily accept markings).
  • a replaceable note-taking layer or stack 500 of layers can overlie all of backlit area 150, including dynamic display 150, with different properties on different areas of the layer(s) that determine areas that are markable and not markable.
  • none of dynamic display 152 includes a note-taking surface, but backlit area 150 includes a note- taking surface that adjoins the dynamic display.
  • any suitable note-taking surface of the present disclosure could include permanent markings that could serve, for example, as prompts for written notes (e.g., "Dose ", "Rate ", and so on).
  • a dynamic display could dynamically provide similar prompts or guides for written notes.

Abstract

Une pompe à perfusion peut comprendre un réceptacle configuré pour recevoir une seringue et un volet de réceptacle qui peut être fixé de manière pivotante à la pompe. Le volet de réceptacle peut pivoter entre un mode ouvert et un mode fermé. Dans le mode fermé, le volet de réceptacle est dans une position qui empêche essentiellement l'accès au réceptacle et à la seringue contenue dans le réceptacle. Dans le mode ouvert, le volet de réceptacle est dans une position qui permet l'accès au réceptacle et à la seringue contenue dans le réceptacle. Le volet de réceptacle peut comprendre une surface structurée pour le marquage effaçable compatible avec un dispositif de marquage.
PCT/US2016/027254 2015-04-27 2016-04-13 Systèmes et procédés pour fournir des surfaces de prise de notes sur des pompes à perfusion WO2016176042A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562153203P 2015-04-27 2015-04-27
US62/153,203 2015-04-27

Publications (1)

Publication Number Publication Date
WO2016176042A1 true WO2016176042A1 (fr) 2016-11-03

Family

ID=57199532

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2016/027254 WO2016176042A1 (fr) 2015-04-27 2016-04-13 Systèmes et procédés pour fournir des surfaces de prise de notes sur des pompes à perfusion

Country Status (1)

Country Link
WO (1) WO2016176042A1 (fr)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD789516S1 (en) * 2013-12-20 2017-06-13 Deka Products Limited Partnership Medical pump
USD801519S1 (en) 2015-02-10 2017-10-31 Deka Products Limited Partnership Peristaltic medical pump
USD803386S1 (en) 2015-02-10 2017-11-21 Deka Products Limited Partnership Syringe medical pump
USD803387S1 (en) 2015-02-10 2017-11-21 Deka Products Limited Partnership Syringe medical pump
USD804017S1 (en) 2013-06-11 2017-11-28 Deka Products Limited Partnership Medical pump
USD805183S1 (en) 2015-02-10 2017-12-12 Deka Products Limited Partnership Medical pump
USD816685S1 (en) 2013-12-20 2018-05-01 Deka Products Limited Partnership Display screen of a medical pump with a graphical user interface
USD817480S1 (en) 2013-06-11 2018-05-08 Deka Products Limited Partnership Medical pump
USD817479S1 (en) 2013-06-11 2018-05-08 Deka Products Limited Partnership Medical pump
KR101969392B1 (ko) * 2017-11-24 2019-08-13 에이치로보틱스 주식회사 마취액 주입 장치

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4943279A (en) * 1988-09-30 1990-07-24 C. R. Bard, Inc. Medical pump with infusion controlled by a detachable coded label
US5954697A (en) * 1998-03-02 1999-09-21 Srisathapat; Chad Threaded nut syringe plunger for use with a medication infusion pump
WO2005046768A1 (fr) * 2003-11-04 2005-05-26 Medex, Inc. Systeme de detection rapide d'occlusion dans une pompe a perfusion
US7236936B2 (en) * 1999-12-01 2007-06-26 B. Braun Medical, Inc. Security infusion pump with bar code reader
WO2014097366A1 (fr) * 2012-12-17 2014-06-26 テルモ株式会社 Seringue munie d'une étiquette pendante

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4943279A (en) * 1988-09-30 1990-07-24 C. R. Bard, Inc. Medical pump with infusion controlled by a detachable coded label
US5954697A (en) * 1998-03-02 1999-09-21 Srisathapat; Chad Threaded nut syringe plunger for use with a medication infusion pump
US7236936B2 (en) * 1999-12-01 2007-06-26 B. Braun Medical, Inc. Security infusion pump with bar code reader
WO2005046768A1 (fr) * 2003-11-04 2005-05-26 Medex, Inc. Systeme de detection rapide d'occlusion dans une pompe a perfusion
WO2014097366A1 (fr) * 2012-12-17 2014-06-26 テルモ株式会社 Seringue munie d'une étiquette pendante

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD804017S1 (en) 2013-06-11 2017-11-28 Deka Products Limited Partnership Medical pump
USD814021S1 (en) 2013-06-11 2018-03-27 Deka Products Limited Partnership Medical pump
USD817480S1 (en) 2013-06-11 2018-05-08 Deka Products Limited Partnership Medical pump
USD817479S1 (en) 2013-06-11 2018-05-08 Deka Products Limited Partnership Medical pump
USD789516S1 (en) * 2013-12-20 2017-06-13 Deka Products Limited Partnership Medical pump
USD816685S1 (en) 2013-12-20 2018-05-01 Deka Products Limited Partnership Display screen of a medical pump with a graphical user interface
USD801519S1 (en) 2015-02-10 2017-10-31 Deka Products Limited Partnership Peristaltic medical pump
USD803386S1 (en) 2015-02-10 2017-11-21 Deka Products Limited Partnership Syringe medical pump
USD803387S1 (en) 2015-02-10 2017-11-21 Deka Products Limited Partnership Syringe medical pump
USD805183S1 (en) 2015-02-10 2017-12-12 Deka Products Limited Partnership Medical pump
KR101969392B1 (ko) * 2017-11-24 2019-08-13 에이치로보틱스 주식회사 마취액 주입 장치

Similar Documents

Publication Publication Date Title
WO2016176042A1 (fr) Systèmes et procédés pour fournir des surfaces de prise de notes sur des pompes à perfusion
ES2740550T3 (es) Dispositivo de autoinyección con indicador para indicar la conexión adecuada de componentes
AU2011264076B2 (en) Apparatus and case for infusion equipment
US8114066B2 (en) Display for an infusion delivery system
RU2426515C2 (ru) Упаковка для установочного устройства
CN101522235B (zh) 带有用于驱动储液器中柱塞的驱动装置的输注介质递送装置和方法
AU2009290976B2 (en) Delivery device for use with a therapeutic drug
ES2479442T3 (es) Contenedor para objetos punzantes
US6279759B1 (en) Medication recordkeeping apparatus
US10307339B2 (en) Multi-compartment medicine storage and dispensing container
EP2716314B1 (fr) Set d'infusion avec dispositif de sécurité
US9290302B2 (en) Medicine dispensing record system
US20150108016A1 (en) Medicine Dispensing Record System
US9934366B1 (en) Medicine management and identification system and kit
JP2012040389A (ja) ペン注射装置ニードル供給および収納装置
JP2015512759A (ja) 不用意な起動を防ぐ安全機能を備えた注入装置
US20140252177A1 (en) Multiple intravenous line organizer and method for using thereof
US9033154B2 (en) Infection prevention system with IV pole flush and swab caddy
CN209951919U (zh) 能够承载医疗装置的包装组件
ES2948459T3 (es) Dispositivo de etiquetado de jeringa
JP5886445B2 (ja) タグ懸吊りシリンジ
US10918570B1 (en) Medication container information concealment and tracking system
US20040068902A1 (en) Tag for intravenous infusion systems
CN206782178U (zh) 一种药房配药器
JP2022532489A (ja) ペンニードルマガジン

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16786914

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16786914

Country of ref document: EP

Kind code of ref document: A1